31 Oct 2025 | 3 Mins Read
Strides Pharma shares surge 13% on strong margins, US guidance affirmed
Flipitmoney
Strides Pharma Ltd's shares surged 13%, closing near ₹972, its 52-week high, on October 31st, following its September quarter results, which showed an 82% increase in net profit to ₹131.5 crore and 4.6% revenue growth. EBITDA increased 25.4% to ₹232 crore, with a 300-basis-point expansion in EBITDA margin to 19%.